M.S. Raghavan Ayyangar: A Pillar of Expertise on TECCRO’s Board of Advisors
TECCRO is proud to welcome M. S. Raghavan Ayyangar (MSR) to our Board of Advisors, where his wealth of knowledge and extensive experience will be invaluable in guiding our mission of advancing ethical clinical research. With over five decades in engineering, business management, and holistic healthcare, MSR brings a unique perspective that seamlessly integrates modern scientific approaches with traditional wisdom.
His distinguished career has been marked by innovative leadership, making significant contributions to various sectors. As a member of our Ethics Committee, MSR ensures that our clinical trials uphold the highest standards of safety and integrity, reinforcing our commitment to patient-centric care. His insights into ethical research practices are instrumental in shaping TECCRO’s strategies, enabling us to navigate the complexities of the healthcare landscape effectively.
MSR’s visionary approach not only enhances our operational framework but also inspires our team to push the boundaries of clinical research. With his guidance, TECCRO is well-positioned to drive groundbreaking discoveries that improve healthcare outcomes globally. MSR’s presence on our Board of Advisors symbolizes our dedication to excellence and innovation in clinical research, ensuring we remain at the forefront of the industry.
Mr. Sridhar Ranganathan: A Visionary Leader Enhancing TECCROs Board of Advisors
TECCRO proudly welcomes Mr. Sridhar Ranganathan to its Board of Advisors. With over 21 years of experience in the healthcare industry, his extensive knowledge and leadership make him an invaluable asset to our organization. Mr. Ranganathan’s career includes a long tenure at Allergan, where he excelled as Managing Director of Allergan India and Associate Vice President for International Business, based in the UK. His strategic acumen in sales and marketing has consistently driven business growth and innovation.
Currently the Co-Founder and CEO of Helyxon Healthcare Solutions Pvt Ltd, a MedTech company in collaboration with IIT Madras, Mr. Ranganathan is also a member of the Steering Committee of the HRD Department of Biotechnology, Ministry of Science and Technology. His guidance extends to advising healthcare companies and mentoring entrepreneurs, reflecting his commitment to fostering innovation and leadership in the healthcare sector.
Mr. Ranganathan’s expertise, vision, and strategic insights will be instrumental in advancing TECCRO’s mission to lead groundbreaking clinical research and healthcare solutions. His role on our advisory board marks a significant step forward as we continue to push the boundaries of medical science.
Dr. Gopakumar Nair: Shaping the Future of Innovation Through Intellectual Property insights at TECCRO
TECCRO is privileged to welcome Dr. Gopakumar Nair, a pioneer in intellectual property (IP) rights, to its Board of Advisors. With over 40 years of experience in the pharmaceutical industry and unparalleled expertise in IP law, Dr. Nair’s contribution will be crucial in driving TECCRO’s innovation strategy. As a trailblazer in the patent landscape, he has not only safeguarded groundbreaking inventions but also unlocked their potential for global impact. His leadership in establishing strategic IP frameworks through his firm, GNANlex Associates and as CEO of Patent Gurukul, positions him as a key figure in navigating complex patent challenges.
Dr. Nair’s distinguished background, including a Ph.D. from the National Chemical Laboratory and dual law degrees, ensures a powerful blend of scientific and legal expertise. His tenure as Chairman of the IPR Committee for the Indian Drug Manufacturers’ Association (IDMA) reflects his strategic mastery in IP protection and commercialization. With Dr. Nair’s visionary approach to patent management, TECCRO will be well-equipped to protect and scale its pioneering research, ensuring both compliance and a competitive edge in the global clinical research arena.